Published September 1, 2005
Nongynecological Cytology Practice Guidelines
This link shows the American Society of Cytopathology’s (ASC) nongynecological cytology reporting guidelines.
Reporting Guidelines (Microsoft
Word, 23 K)
This document was created by the CAP Cytopathology Committee regarding reporting nongynecologic and FNA specimens. Examples of what would be considered bad reports are also provided.
Report Overview from Quality Management Manual
(PDF, 32 K)
This document, written by Theresa M. Voytek, MD, Dina R. Mody, MD, and Diane D. Davey, MD, is taken from Quality Management in Anatomic Pathology and addresses cytopathology and FNA reports.
Ronald L. Sirota, MD, FCAP, suggests this language as a standard comment/disclaimer for negative FNABs:
“Hypocellularity may indicate that the specimen is unsatisfactory for interpretation.”
“Technical considerations such as needle placement can cause a false negative or equivocal result.”
“Negative NFAB results should not preclude tissue biopsy if FNAB results do not correlate with clinical impressions.”
Ronald L. Sirota, MD, FCAP, suggests this language as a standard comment/disclaimer for negative cytology:
“Non-diagnostic cytological results should not preclude tissue biopsy if they do not correlate with clinical impressions.”
Ronald L. Sirota, MD, FCAP, suggests this language as a standard comment/disclaimer for positive cytology:
“When possible, cytology findings should be confirmed with histological studies or frozen section before undertaking definitive therapy.”
Liver FNA sample report (PDF, 84 K)
Lung FNA sample report (PDF, 93 K)
Lung FNA sample report 2 (PDF, 95 K)
Narrative neck FNA sample report (PDF, 112 K)
Thyroid FNA sample report (PDF, 85 K)